U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Repetitive compulsive behavior

MedGen UID:
409891
Concept ID:
C1969697
Finding; Mental or Behavioral Dysfunction
Synonym: Repetitive compulsive behaviour
 
HPO: HP:0008762

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRepetitive compulsive behavior

Conditions with this feature

GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
MedGen UID:
375285
Concept ID:
C1843792
Disease or Syndrome
The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive nonfluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.
Syndromic X-linked intellectual disability Lubs type
MedGen UID:
337496
Concept ID:
C1846058
Disease or Syndrome
MECP2 duplication syndrome is a severe neurodevelopmental disorder characterized by early-onset hypotonia, feeding difficulty, gastrointestinal manifestations including gastroesophageal reflux and constipation, delayed psychomotor development leading to severe intellectual disability, poor speech development, progressive spasticity, recurrent respiratory infections (in ~75% of affected individuals), and seizures (in ~50%). MECP2 duplication syndrome is 100% penetrant in males. Occasionally females have been described with a MECP2 duplication and a range of findings from mild intellectual disability to a phenotype similar to that seen in males. In addition to the core features, autistic behaviors, nonspecific neuroradiologic findings on brain MRI, mottled skin, and urogenital anomalies have been observed in several affected boys.
Developmental delay, impaired speech, and behavioral abnormalities
MedGen UID:
1794167
Concept ID:
C5561957
Disease or Syndrome
Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) is characterized by global developmental delay apparent from early childhood. Intellectual disability can range from mild to severe. Additional variable features may include dysmorphic facial features, seizures, hypotonia, motor abnormalities such as Tourette syndrome or dystonia, and hearing loss (summary by Cousin et al., 2021).

Professional guidelines

PubMed

Lee DK, Lipner SR
Int J Environ Res Public Health 2022 May 24;19(11) doi: 10.3390/ijerph19116370. PMID: 35681955Free PMC Article
Lee DK, Lipner SR
Int J Environ Res Public Health 2022 Mar 13;19(6) doi: 10.3390/ijerph19063392. PMID: 35329078Free PMC Article
Woods DW, Houghton DC
Psychiatr Clin North Am 2014 Sep;37(3):301-17. Epub 2014 Jul 21 doi: 10.1016/j.psc.2014.05.005. PMID: 25150564Free PMC Article

Recent clinical studies

Etiology

Kwee CMB, Leen NA, Van der Kamp RC, Van Lissa CJ, Cath DC, Groenink L, Baas JMP
Eur Neuropsychopharmacol 2023 Jul;72:79-94. Epub 2023 Apr 23 doi: 10.1016/j.euroneuro.2023.04.001. PMID: 37094409
Erickson CA, Weng N, Weiler IJ, Greenough WT, Stigler KA, Wink LK, McDougle CJ
Brain Res 2011 Mar 22;1380:264-70. Epub 2010 Nov 5 doi: 10.1016/j.brainres.2010.10.108. PMID: 21059347

Therapy

Kwee CMB, Leen NA, Van der Kamp RC, Van Lissa CJ, Cath DC, Groenink L, Baas JMP
Eur Neuropsychopharmacol 2023 Jul;72:79-94. Epub 2023 Apr 23 doi: 10.1016/j.euroneuro.2023.04.001. PMID: 37094409
Erickson CA, Weng N, Weiler IJ, Greenough WT, Stigler KA, Wink LK, McDougle CJ
Brain Res 2011 Mar 22;1380:264-70. Epub 2010 Nov 5 doi: 10.1016/j.brainres.2010.10.108. PMID: 21059347

Clinical prediction guides

Kwee CMB, Leen NA, Van der Kamp RC, Van Lissa CJ, Cath DC, Groenink L, Baas JMP
Eur Neuropsychopharmacol 2023 Jul;72:79-94. Epub 2023 Apr 23 doi: 10.1016/j.euroneuro.2023.04.001. PMID: 37094409
Bahceci D, Anderson LL, Occelli Hanbury Brown CV, Zhou C, Arnold JC
Epilepsy Behav 2020 Feb;103(Pt A):106842. Epub 2019 Dec 20 doi: 10.1016/j.yebeh.2019.106842. PMID: 31870807
Erickson CA, Weng N, Weiler IJ, Greenough WT, Stigler KA, Wink LK, McDougle CJ
Brain Res 2011 Mar 22;1380:264-70. Epub 2010 Nov 5 doi: 10.1016/j.brainres.2010.10.108. PMID: 21059347

Recent systematic reviews

Kwee CMB, Leen NA, Van der Kamp RC, Van Lissa CJ, Cath DC, Groenink L, Baas JMP
Eur Neuropsychopharmacol 2023 Jul;72:79-94. Epub 2023 Apr 23 doi: 10.1016/j.euroneuro.2023.04.001. PMID: 37094409

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...